Government’s denial of Avastin a sign of things to come under ObamaCare

Under the new health overhaul law, far too many medical decisions will be made by bureaucrats — not doctors and patients. Treatment of the new breast cancer drug Avastin provides a foreboding example. (Richmond Times Dispatch) More > …

ObamaCare killing medical innovation

“The Avastin story is emblematic of the government’s broader agenda to ration care based on cost and politics. If government can limit Americans’ choice of effective medical treatments, there’s no limit to its control over our bodies, and the right to bodily autonomy is an illusion.  In the context of the new health law, the FDA’s Avastin decision is the tip of a looming iceberg of government rationing. It must be challenged.” (American Spectator) More > …

It’s not a tumor!

Let’s just say with regards to the Avastin distraction, the FDA isn’t allowed to distinguish between drugs that work and drugs that don’t, there isn’t really much reason for it to be around at all (Forbes) More > …

The Avastin distraction

According to Red State, Obamacare is worth 17.5k dead women a year. Under Obamacare the government would have to be the one to make the awkward and politically fraught call on whether or not to spend a lot of money making available a drug that doesn’t magically destroy cancer on the spot. (Red State / Wall Street Journal) More > …